WHO has sounded alarm over a sharp spike in HIV cases in the Philippines, Fiji and Papua New Guinea, urging urgent prevention ...

On October 20, 2025, scientists announced a significant advancement toward curing HIV, marking a pivotal moment in the ...

Abbvie (($ABBV)) announced an update on their ongoing clinical study. AbbVie recently updated its clinical study titled A ...

The rate of HIV infection continues to climb globally. Around 40 million people live with HIV-1, the most common HIV strain.

It found that across the 34 emergency departments taking part in the programme, 3,667 people were newly diagnosed with ...

GSK raised its 2025 sales and earnings forecasts on Wednesday as its speciality HIV and cancer drugs posted double digit ...

The locations with the greatest risk of catching HIV have been revealed as nearly 200 more people in Yorkshire were diagnosed ...

A University of Massachusetts Amherst public health researcher has received four grants totaling $17.9 million from the ...

Leaders in HIV research highlighted the critical role of that research has played in advancing HIV science over the past 40 years. In a commentary in Nature Medicine, they explained how U.S.-funded ...

There were still 32,000 new cases of HIV in the U.S. in 2022. And about thousands of people still die annually from AIDS. HIV ...

HIV prevention drug Lenacapavir, which has been tested in South Africa during clinical trials, will be made available in the country in 2026 for high-risk groups.

Shionogi now plans to accelerate its expansion in Europe and the U.S., while pursuing full-scale growth of its new drug ...